MVP: Vegan and Omnivorous Diets and Skeletal Muscle Turnover in Healthy Older Adults

Sponsor
University of Exeter (Other)
Overall Status
Recruiting
CT.gov ID
NCT05985369
Collaborator
(none)
24
1
2
13.7
1.8

Study Details

Study Description

Brief Summary

Dietary protein intake and physical activity are key to minimise the age-related loss of skeletal muscle mass. While animal-derived protein sources are considered high-quality anabolic foods, it remains unclear whether non-animal-derived (vegan) protein sources support skeletal muscle maintenance and healthy ageing. The aim of the present study is to assess the effect of a vegan diet on daily muscle protein synthesis rates compared to a protein-matched omnivorous diet where the majority of protein is derived from high-quality animal-based protein sources.

Condition or Disease Intervention/Treatment Phase
  • Other: Controlled diet and resistance exercise
N/A

Detailed Description

Background: The age-related loss of muscle mass and strength is (partly) explained by a blunted responsiveness of skeletal muscle to the anabolic properties of dietary protein and muscle contraction. Therefore, sufficient dietary protein intake and physical activity are required to minimise age-related muscle atrophy. It remains unknown whether this can be achieved utilising non-animal-derived (vegan) protein sources.

Objective: To assess daily muscle protein synthesis rates when adopting a vegan or protein-matched omnivorous control diet.

Methods: Healthy older adults (aged 60-80 years) will be randomly allocated to a completely controlled 1-week vegan (providing 0.8 g/kg BW/day protein) or protein-matched omnivorous diet. During this week, participants will perform a set of unilateral leg resistance exercise on day 1, 3, and 5. Deuterium oxide in combination with saliva and muscle sample (from the m. vastus lateralis) collection will be used to measure daily muscle protein synthesis rates in resting and exercised tissue.

Value: This will be the first study assessing daily muscle protein turnover in healthy older adults adopting a 1-week vegan diet. This will contribute to the understanding and viability of vegan protein to support active and healthy ageing.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Effects of a High-quality Vegan Diet on Skeletal Muscle Maintenance and Adaptation in Comparison to a Protein-matched Omnivorous Diet in Healthy Older Adults.
Actual Study Start Date :
Nov 9, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vegan diet

Participants will be allocated to a fully controlled 1-week vegan diet containing 0.8 g/kg BW/day of protein where all protein provided will be derived from non-animal-derived protein sources.

Other: Controlled diet and resistance exercise
Participants will adopt a 1-week completely controlled diet and perform 3 sessions of unilateral leg resistance exercise.

Experimental: Omnivorous diet

Participants will be allocated to a fully controlled 1-week omnivorous diet containing 0.8 g/kg BW/day of protein where the majority of protein will be derived from animal-derived protein sources.

Other: Controlled diet and resistance exercise
Participants will adopt a 1-week completely controlled diet and perform 3 sessions of unilateral leg resistance exercise.

Outcome Measures

Primary Outcome Measures

  1. Muscle protein synthesis (MPS) in resting and exercised tissue [7 days]

    Daily MPS rates, expressed as fractional synthetic rate (%/h)

Secondary Outcome Measures

  1. Muscle morphology [7 days]

    Changes in muscle thickness during the intervention period, measured via ultrasound

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI between 18.5 - 30

  • Active (not very sedentary and not master athlete; assessed via IPAQ)

  • Women only: post menopause

Exclusion Criteria:
  • Hypertension (>150/90 mmHg)

  • Any diagnosed metabolic impairment

  • Any diagnosed cardiovascular disease

  • Any diagnosed gastrointestinal disease

  • Diagnosed cancer

  • Any medication known to affect muscle metabolism (e.g. hormone replacement therapy)

  • Severe food allergies or intolerances (e.g. celiac, lactose intolerance, allergic to fungi or algae foods)

  • Smoking

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Exeter Exeter Devond United Kingdom EX1 2LU

Sponsors and Collaborators

  • University of Exeter

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Exeter
ClinicalTrials.gov Identifier:
NCT05985369
Other Study ID Numbers:
  • 524790
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Exeter

Study Results

No Results Posted as of Aug 14, 2023